サクビトリル・バルサルタン
1 2 3 4 5 6 7 8 “Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure”. New England Journal of Medicine 371 (11): 993–1004. (September 2014). doi:10.1056/NEJMoa1409077. hdl:2336/552372. ISSN 0028-4793. PMID 25176015. http://www.hirsla.lsh.is/lsh/handle/2336/552372.
1 2 3 4 5 “Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure”. New England Journal of Medicine 380 (6): 539–548. (February 2019). doi:10.1056/NEJMoa1812851. ISSN 0028-4793. PMID 30415601.
↑ Mutschler, Ernst; Schäfer-Korting, Monika (2001) (ドイツ語). Arzneimittelwirkungen (8 ed.). Stuttgart: Wissenschaftliche Verlagsgesellschaft. p. 579. ISBN 978-3-8047-1763-3
↑ “Heart Failure with Preserved Ejection Fraction”. J. Cardiovasc. Pharmacol. 62 (1): 13–21. (2013). doi:10.1097/FJC.